top of page


  • Resolution of inflammation after cardiac arrest

  • NIH/NHLBI R01HL166487

  • PI: Kim ($2,152,844)

  • Immune checkpoints as a therapeutic target in cardiac arrest.


  • Deferoxamine for the prevention of acute kidney injury

  • NIH/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK125786

  • (PI: David Leaf)

  • RCT of iron chelation therapy in cardiothoracic surgery.


  • Transformational Project Award: I-CAN: A collaborative research network to discover immunological therapies for cardiac arrest

  • American Heart Association 20TPA35500016

  • PI: Kim ($272,730)

  • Discovery methods in clinical cardiac arrest.


  • T cell – fibroblast axes drive early, unclassified interstitial lung disease

  • American Lung Association DA-827785

  • PI: Kim ($100,000)

  • Define cellular interactions driving inflammatory unclassified lLD.


  • Molecular target identification in unclassifiable interstitial lung disease (ulLD)

  • Brigham and Women’s Hospital Bell Family Award

  • PI: Kim ($25,000)

  • Discovery platforms on lung tissue from patients with earlier-stage ILD.


  • Hepcidin-Ferroportin-Iron axis in cardiac surgery-associated acute kidney injury

  • NIH/NIDDK R01DK126685

  • (PI: David Leaf)

  • Association of hepcidin and iron regulatory pathways with acute kidney injury in patients undergoing cardiac surgery.

bottom of page